Mário Reis Álvares‐da‐Silva

Author

Universidade Federal do Rio Grande do Sul ORCID

Also Known As

Carlos Rodriguez De Lope, Cleber D. P. Kruel, João Lucidio Lobato Paes, Julia V S Matos, Khalid Alswat, M R Alvares-Da-Silva, M R Alvares-da-Silva, M Silva, M. Alvares-da-Silva, M. R. Álvares-da-Silva

335

Publications

4.7K

Citations

H-Index

130

Concepts

All Affiliations

Universidade Federal do Rio Grande do Sul Hospital de Clínicas de Porto Alegre Universidade de São Paulo Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Hospital Italiano de Buenos Aires

About

Mário Reis Álvares‐da‐Silva is an author at Universidade Federal do Rio Grande do Sul specializing in medicine, hepatology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	25	1.2K
2	Health Sciences	11	11	1.2K
3	Public Health	10	10	359
4	Engineering	2	2	53
5	Applied Physiology	2	2	38

Mário Reis Álvares‐da‐Silva

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
Comparison between handgrip strength, subjective global assessment, and prognostic nutritional index in assessing malnutrition and predicting clinical outcome in cirrhotic outpatients Mário Reis Álvares‐da‐Silva, Themis Reverbel da Silveira Nutrition MalnutritionBody CompositionCirrhotic OutpatientsClinical NutritionSubjective Global Assessment	2005	456
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue, Journal of Hepatology FibrosisHepatologyLiver PhysiologyClinical TrialsPathology	2020	438
Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis Kris V. Kowdley, Christopher L. Bowlus, Cynthia Levy, New England Journal of Medicine	2023	213
Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease Juan Pablo Arab, Melisa Dirchwolf, Mário Reis Álvares‐da‐Silva, Annals of Hepatology	2020	134
Effects of Hepatitis C virus on cardiovascular risk in infected patients: A comparative study Cláudia P. Oliveira, C Kappel, Érika Rabelo Forte de Siqueira, International Journal of Cardiology Cardiovascular EpidemiologyCardiovascular DiseaseHepatitis CViral HepatitisHepatology	2011	90
Significant Variations in Elastometry Measurements Made Within Short-term in Patients With Chronic Liver Diseases Fabio Nascimbeni, Pascal Lebray, Larysa Fedchuk, Clinical Gastroenterology and Hepatology Significant VariationsBody CompositionHepatologyMeasurementLiver Physiology	2014	80
Circulating levels of citrullinated and MMP-degraded vimentin (VICM) in liver fibrosis related pathology. Efstathios Vassiliadis, Cláudia P. Oliveira, Mário Reis Álvares‐da‐Silva, PubMed	2012	63
Does the risk of cardiovascular events differ between biopsy-proven NAFLD and MAFLD? Gabriel Tayguara Silveira Guerreiro, Larisse Longo, Mariana Fonseca, Hepatology International Cardiovascular DiseaseBiopsy-proven NafldPublic HealthMedicineAtherosclerosis	2021	62
Assessing the impact of COVID-19 on liver cancer management (CERO-19) Sergio Muñoz, Víctor Sapena, Alejandro Forner, JHEP Reports	2021	60
Oral l‐ornithine‐l‐aspartate in minimal hepatic encephalopathy: A randomized, double‐blind, placebo‐controlled trial Mário Reis Álvares‐da‐Silva, Alexandre de Araújo, João Reinhardt Vicenzi, Hepatology Research	2013	59

Page 1